Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 babalola2022ivermectin
%A olufemi Emmanuel Babalola,
%A Ajayi, Adesuyi A.
%A Yunusa, Thairu
%A Ndanusa, Yahaya
%A Ogedengbe, John O.
%A Ogu, Omede
%D 2022
%I Research Square Platform LLC
%J Research Square
%K covid-19 ivermectin
%R 10.21203/rs.3.rs-1576399/v1
%T Ivermectin is associated with increase in SPO2 in hypoxemic SARS-Cov-2 patients: pharmacodynamic profile and correlates.
%U https://doi.org/10.21203/rs.3.rs-1576399/v1
@article{babalola2022ivermectin,
added-at = {2023-02-05T10:34:28.000+0100},
author = {olufemi Emmanuel Babalola and Ajayi, Adesuyi A. and Yunusa, Thairu and Ndanusa, Yahaya and Ogedengbe, John O. and Ogu, Omede},
biburl = {https://www.bibsonomy.org/bibtex/258ab27ee47b41e6da9c36b80325e403a/fordham1},
description = {Ivermectin is associated with increase in SPO2 in hypoxemic SARS-Cov-2 patients: pharmacodynamic profile and correlates. | Research Square},
doi = {10.21203/rs.3.rs-1576399/v1},
interhash = {b0de3ee5825a95f23d0c4a9df0c6aa66},
intrahash = {58ab27ee47b41e6da9c36b80325e403a},
journal = {Research Square},
keywords = {covid-19 ivermectin},
month = apr,
publisher = {Research Square Platform {LLC}},
timestamp = {2023-02-05T10:35:59.000+0100},
title = {Ivermectin is associated with increase in {SPO}2 in hypoxemic {SARS}-Cov-2 patients: pharmacodynamic profile and correlates.},
url = {https://doi.org/10.21203/rs.3.rs-1576399/v1},
year = 2022
}